Background Among elderly with severe aortic stenosis (AS), Comprehensive Geriatric Assessment (CGA) originally contributed to address to transcatheter aortic valve implantation (TAVI) patients not suitable to surgical aortic valve replacement(SAVR). Nevertheless, TAVI has recently been proposed also in lower surgical risk patients. Aims To evaluate predictors of TAVI procedure and clinical outcomes among these patients. Methods For each patient ≥ 65 years with severe AS referring to our Cardiac Surgery Division, CGA was performed, including functional and cognitive status, comorbidity burden, frailty, nutritional status, gait speed, hand-grip strength and number of medications. Surgical risk was evaluated according to the Society of Thoracic Surgeons (STS) score (low-risk < 4%). Post-procedural outcomes (30-day survival and post-procedural complications) were obtained by medical records and a one-year follow-up assessed survival, and functional and cognitive performance. Results Among 154 subjects (mean age 82.9 years), 52 were at low-risk according to STS score. 32 patients were addressed to TAVI, 20 to SAVR. Variables significantly associated with TAVI-approach were lower gait speed (p 0.030) and higher number of medications (p 0.015). Short and long-term outcomes did not differ between groups. Discussion Among CGA variables, gait speed and number of medications were associated with the decision to perform TAVI instead of SAVR, even in patients at low surgical risk. 30-day and one-year survival and one-year functional and cognitive decline were similar between groups, despite a relevant prevalence of frailty in the TAVI group. Conclusions We suggest that gait speed and number of medications should be considered in selecting appropriate candidates to TAVI among low surgical risk patients.
Introduction
The prevalence of degenerative aortic stenosis (AS) increases with advancing age, and, with demographic shift, has become one of the most common valvular heart diseases in developed countries [1] . It is estimated that an AS of any degree is present roughly in 40% of adults over 80 years, and up to 3.4% have a severe AS [2] . According to current guidelines, aortic valve replacement should be considered in symptomatic severe AS, regardless of patient's age at presentation, when life expectancy is greater than 1 year, and quality of life is likely to improve after valve replacement [3, 4] . Surgical aortic valve replacement (SAVR) is the treatment option for all patients with symptomatic AS, except those at prohibitive surgical risk [3, 4] . Transcatheter aortic valve implantation (TAVI) was originally developed as a minimally invasive option for inoperable patients, and further broadened to those at high surgical risk [5] . However, the technical advances and the increased operator experience, along with the encouraging results from randomized and observational studies [6] [7] [8] , have progressively made TAVI an attractive option for patient at lower surgical risk, as demonstrated by the updated guidelines that acknowledged 1 3 TAVI as a reasonable alternative to SAVR in intermediate risk patients (class II A) [4] .
Several surgical scores, including the Society of Thoracic Surgeons' (STS) score [9] , are routinely used to predict postoperative mortality; however, these scores have some limitations, because they do not consider procedure specific impediments and advanced age-associated conditions, such as comorbidities or frailty [3] which have been demonstrated to influence survival and clinical outcomes in these patients [10, 11] .
The comprehensive geriatric assessment (CGA) has been initially used to refine prognosis, to avoid futile interventions. With the expanded TAVI indications, CGA is currently proposed as a contributor, within the multidisciplinary Heart Team, to improve candidate selection for less invasive approach among patients at high and intermediate surgical risk [10] [11] [12] .
However, older patients at low surgical risk are a heterogeneous population, and might also have poor functional or cognitive statuses, or geriatric syndromes such as frailty, potentially influencing post procedural survival and clinical outcomes. Therefore, CGA might have the potential also to pick out those patients at low surgical risk who will benefit most by a less invasive technique such as TAVI.
To the best of our knowledge, whether CGA and its components affect procedural decisions in low-risk older patients with severe AS has never been explored. In this study, reporting the experience of our center within the Heart Team, we aimed to investigate which variables of CGA were associated with the decision to perform TAVI instead of SAVR in low-risk patients, and to compare shortterm and one-year outcomes.
Methods
The population for this study was obtained from a prospective registry, including all patients with symptomatic severe AS referring to the cardiac division of a tertiary teaching hospital (City of Health and Science, Turin, Italy) for preoperative evaluation. In our center, the interdisciplinary Heart Team includes, beyond cardiologists, cardiac surgeons, cardiovascular imaging experts and anaesthesiologists, four geriatric residents under the supervision of a senior geriatrician, and CGA is routinely carried on in older subjects. Written informed consent was obtained from all patients. The treatment decision for each case was made on the basis of consensus, after collegial discussion.
Patients systematically evaluated by the Heart Team between March 2013 and May 2015 were considered for this study. Inclusion criteria were as follows: (1) Demographic, clinical and echocardiographic information were recorded at enrolment. The STS score was calculated by the cardiac surgeon or the cardiologist, and patients were defined at low risk with an STS score < 4%, according to current guidelines [3, 4] . Each patient underwent a detailed CGA, including: Cumulative Illness Rating Scale-Comorbidity Index (CIRS-CI, range 0-14, with higher score indicating greater burden of comorbidities) [13] , Short Portable Mental Status Questionnaire (SPMSQ, range 0-10, with score > 4 indicating moderate to severe cognitive impairment) [14] , basic Activities of Daily Living (ADL Katz, range 0-6, with score ≥ 1 indicating dependence in basic activities) [15] , Instrumental Activities of Daily Living (IADL, range 0-14, with score < 10 indicating loss of autonomy) [16] , Mini Nutritional Assessment (MNA, range 0-14, with score < 11 indicating patients malnourished or at risk of malnutrition) [17] , frailty assessed by the Green score (range 0-12, with a score > 5 indicating frail status) [11] , gait speed (measured as meters per second (m/s) by asking the patient to walk at his comfortable pace for 5 meters flat), grip strength (measured as kilograms (kg) using an handgrip dynamometer) and the number of medications.
Post-procedural outcomes were obtained by medical records retrieve and included 30-day mortality and postprocedural incidence of delirium, infections, conduction disturbances and arrhythmias, acute kidney injury, major or life-threatening bleedings, stroke and acute myocardial infarctions, as defined by the Valve Academic Research Consortium [18] . 1-year follow-up was conducted by the same geriatricians through office visits or telephone interview with patients or usual caregivers, to ascertain vital status, and functional (ADL and IADL performances) and cognitive performance (through SPMSQ questionnaire) at 1-year. For deceased patients date of death was also recorded.
Statistical analysis
Categorical variables and outcomes are presented as number (percentage) with p value indicating results of Chi-square test between treatment groups. Continuous variables presented as mean ± standard deviation with p-value indicating result of 1-way ANOVA (or, if the groups were not 1 3
homogeneous, a Kruskal-Wallis test was performed). Variables from CGA were introduced in a multivariate logistic regression model (Enter method) to identify those associated with treatment decision. Odds ratio with their 95% confidence intervals were presented. Univariate survival analysis using the Kaplan-Mayer survival curves was used to compare one-year mortality in TAVI and SAVR patients. Furthermore, we performed a Cox proportional-hazard regression analysis to evaluate which variables from CGA were associated with mortality in the overall sample. All tests were two-sided, and a level of significance was established as 95% (p < 0.05). Statistical analyses were performed using MedCalc Statistical Software version 17.0.4 (MedCalc Software bvba, Ostend, Belgium).
Results
During the observation period 280 patients have been evaluated in our center; 24 were excluded because of age < 65 years, 56 had a reduced life expectancy and were addressed to medical therapy, 30 were excluded in reason of incomplete data and 16 were excluded because not suitable to TAVI in reason of anatomical or clinical characteristics.
The final study population consisted of 154 patients (mean age of 82.9 ± 4.9 years, 65.9% females), and the treatment of choice was TAVI in 109 and SAVR in 45 patients. Main demographic and clinical characteristics, according to treatment strategy, are summarized in Table 1 . Mean valve gradient was 50.1 mmHg ± 15.4, mean aortic valve area was 0.60 cm 2 ± 0.17 and mean LVEF was above 50%. Patients addressed to TAVI had overall worse functional, cognitive and nutritional scores, and higher prevalence of cognitive impairment, frailty and disability, furthermore they walked slower and took a higher number of medications daily (Table 1) .
According to conventional risk score (STS < 4%), 52 patients qualified as low risk: 32 of them underwent TAVI and 20 SAVR. In low-risk group 14 out of 52 patients (almost one-third) were frail according to Green score; dependence in ADL and loss of autonomy in IADL were observed in 11.5% and 26.9% of patients, respectively. Polypharmacy was also common, with a mean number of daily medications of 6.3 ± 2.9. Among low-risk patients those Table 2) was independently associated with TAVI procedure. In the overall sample, short-term outcomes were similar in SAVR and TAVI patients, with the only exception of a longer length of stay in TAVI group (p 0.049), whereas among low-risk patients, no significant difference in shortterm outcome was observed (Table 3) .
In the overall sample, one-year mortality rates were 13.3% for SAVR and 16.5% for TAVI (p 0.623). The results of Cox proportional-hazard regression are presented in Table 4 ; the only variable independently associated with mortality was a slower gait speed (HR 0.14; 95% CI 0.02-0.85; p 0.033). Focusing on low-risk patients, one-year mortality rates were similar, with a non-significant trend to lower mortality in TAVI group (12.5% vs 15% in SAVR), as confirmed by Kaplan-Meyer survival analysis (Fig. 1a) . No differences were observed also in terms of functional and cognitive decline at one-year follow-up (Table 3) .
Discussion
In a real-world single-center sample of older patients, with symptomatic severe AS, we observed a relevant prevalence of poor functional status, frailty, polypharmacy, low muscular strength and slow walking speed, even among those defined at low-risk. Within the CGA components investigated, only slower gait speed and higher number of medications were independently associated with the decision to perform TAVI instead of SAVR, both in overall sample and in patients at low-risk. Finally, despite a higher prevalence of frailty and poor functional status in patients undergoing TAVI, mortality and clinical outcomes did not differ from those observed in SAVR group. Present findings suggest that CGA may provide useful clinical information and should be routinely performed in older patients with severe symptomatic AS, including those with estimated low surgical risk.
The presence of frailty and other geriatric syndromes in patients with symptomatic severe AS has been extensively reported in previous studies [10, 19, 20] . The prevalence of frailty was highly variable, ranging from 4% to 50% in SAVR and from 16% to 63% in TAVI cohorts, depending mostly on clinical setting (randomized trials vs observational studies) and frailty criteria adopted; moreover, data focused on low-risk older patients are lacking. In keeping with previous studies, in our sample frailty was present in more than half of patients undergoing valve replacement, and in roughly one-third of those at low surgical risk. However, we observed a relatively low mortality at 1 year, both in patients undergoing TAVI or SAVR, suggesting that the selection performed by the Heart Team was appropriate. Furthermore, short-term outcomes and one-year mortality in our population were in keeping with previous reports [7, 8, 21] .
A European survey on TAVI practice, carried out in 2016, revealed that, among the 310 participating centers, 45% performed TAVI in patients at intermediate risk, and 10% also in patients with an STS < 4% [22] . Interestingly, geriatricians were part of the Heart Team in only 15%, and frailty was routinely assessed in less than one-third of centers [22] .
To the best of our knowledge only few studies investigated factors associated with the decision to perform TAVI instead of SAVR [23, 24] . Kaier and colleagues, in a sample of 124 patients eligible for both procedures, reported that the choice to perform TAVI instead of SAVR was associated with advanced age and higher surgical risk according to EuroSCORE I; however, geriatric variables were not taken into account in this study [23] . In another study including 239 patients (mean age 83 years), Boureau et al. reported that, among domains of geriatric assessment, comorbidities, IADL functional status and physical performance were independently associated with decision-making between TAVI and SAVR [24] ; however, patients were not stratified according to surgical risk score, and outcomes according to treatment strategy were not reported. The heterogeneity of older patients with symptomatic severe AS, in terms of comorbidities, disability, and frailty, makes age alone a poor parameter for procedure selection and an unreliable predictor of procedural success. Indeed, in our sample of patients we did not document significant age differences between patients undergoing TAVI and SAVR. In a recent paper discussing the perspectives of TAVI in lower-risk patients, Tarantini et al. concluded that some elderly patients at low surgical risk will likely benefit from TAVI [25] . Our findings demonstrate that slow walkers were more likely to underwent TAVI, with clinical outcomes similar to those observed in patients who underwent SAVR, thereby providing evidence that in these patients low gait speed might be a simple and useful tool to identify those low-risk patients who might mainly benefit from this approach.
Current guidelines recommend to consider frailty in each potential TAVI candidate and, although no "gold Table 3 Outcome at 30-days and at 1-year follow-up according to treatment Difference was obtained by (score at baseline − score at 1-year follow-up). A negative difference for the ADL, and SPMSQ indicates increased dependency in ADL and cognitive status, respectively; a positive difference for the IADL indicates decreased autonomy TAVI transcatheter aortic valve implantation, SAVR surgical aortic valve replacement, SD standard deviation, ADL activities of daily living, IADL instrumental activities of daily living, SPMSQ short portable mental status questionnaire standard" is defined, the frailty assessment should not rely on an "eyeball test", but rather on an objective measurement. However, decision-making process is often implicit and the best way to manage tools from CGA to improve candidate selection and prediction of relevant clinical outcomes is actually uncertain. In this context, our results suggest that the frailty assessment should include an evaluation of motor performance, such as gait speed. This simple, rapid and inexpensive test effectively stratifies patients beyond traditional estimates of risk, which tend to be inaccurate in elderly, and tend to overestimate mortality in TAVI context [3, 26] . In an article discussing tools at support of decision making process, Lilamand and colleagues proposed to measure the gait speed over 5 meters as initial screening in severe AS, to identify those who should better undergo to CGA before choosing treatment strategy [27] . The authors proposed the use of a traditional cut-off of 0.83 m/s that identifies robust patients; of note in our sample most of patients were slower, including SAVR candidates in low-risk group, that had a mean gait speed of 0.71 m/s. Moreover, gait speed is an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery, associated with a 2-to 3-fold increase in risk [28] , and in a Japanese multicentre registry, it has been suggested that gait speed can also predict advanced clinical outcomes in patients undergoing TAVI [29] . As a marker of frailty, gait speed could be considered a summary indicator of vitality as walking requires integration of circulatory, respiratory, nervous, and musculoskeletal systems [30] . Besides, in older adults with functional decline, decreasing mobility may lead to inactivity and overall deconditioning that contributes to poor health and survival.
Several ongoing trials comparing SAVR to TAVI in lowrisk patients (The PARTNER 3 trial NCT02675114; Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic, severe AS trial NCT02628899; Evolut R low risk trial NCT02701283) will hopefully provide, in the next future, further data on procedure allocation and clinical outcomes of older low-risk patients.
Some limitations of this study must be addressed. The main weakness is clearly the potential for selection bias, which is inherent to the single-center observational nature of the cohort studied. Moreover, due to the relatively small sample size we were not able to define a gait speed threshold that better identify those who should receive TAVI instead of SAVR. Finally, our data are not generalizable to lower-risk younger patient, for whom the strongest argument against TAVI is undoubtedly valve durability and data on long-term follow-up are crucial. Actually, in a population like that in the present study, long-term survival is more likely to be affected to the advanced age and the multiple comorbidities, than to valve failure.
In conclusion, our findings confirm the role of gait speed as predictor of mortality in older patients with AS undergoing valve-replacement and suggest that, in the context of a multidisciplinary decision-making approach, gait speed might have a role in selecting appropriate candidates to TAVI among low surgical risk patients.
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